The GvHD Alliance is proud to announce its expansion into Europe — a significant milestone in its mission to improve the lives of people affected by Graft-versus-Host Disease (GvHD). The European launch was marked by a high-level kick-off meeting on June 16, 2025, bringing together patient advocates, academic leaders, and industry partners. Among the distinguished participants was Meredith Cowden, representing the Meredith A. Cowden Foundation, who shared key insights and learnings from the GvHD Alliance’s collaboration with North American member organisations.
This milestone event will serve as the foundation for a more unified, global response to the challenges of GvHD—a serious and often life-threatening complication of stem cell or bone marrow transplantation. By uniting healthcare professionals, patient advocacy groups, researchers, and policy leaders, the Alliance seeks to foster collaboration and amplify patient voices across Europe.
“We are thrilled to take this important step forward in our global mission,” said Anna Sureda, EBMT President and spokesperson for the GvHD Alliance Europe. “Expanding into Europe allows us to build on the momentum we have established and work even more closely with the international community to improve care, access, and outcomes for patients living with GvHD.”
The June 16 meeting set the strategic direction for the European initiative, including the development of region-specific education, advocacy, and research collaboration programmes. Participants shared insights, aligned on goals, and began shaping the next chapter of the Alliance’s work.
For more information about the GvHD Alliance, please visit: https://www.gvhdalliance.org